Skip to main content

Chest Pathology

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Solventum
SolventumMN - St. Paul
1 program
Auscultate with electronic or mechanical stethoscopeN/A1 trial
Active Trials
NCT01665820Completed30Est. Dec 2012
Innova Therapeutics
Innova TherapeuticsSC - Mt. Pleasant
1 program
NoaScopeN/A1 trial
Active Trials
NCT05252130Completed47Est. Feb 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Innova TherapeuticsNoaScope
SolventumAuscultate with electronic or mechanical stethoscope

Clinical Trials (2)

Total enrollment: 77 patients across 2 trials

Comparison of NoaScope to the Conventional Stethoscope for Auscultation of Heart and Lung Sounds

Start: Dec 2021Est. completion: Feb 202247 patients
N/ACompleted
NCT01665820SolventumAuscultate with electronic or mechanical stethoscope

Auscultate Obese Patients Using Electronic and Traditional Stethoscopes

Start: Oct 2012Est. completion: Dec 201230 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.